TRANSFORM: LDL – C Risk, an ACC Initiative to Reduce ASCVD Risk Among Secondary Prevention Patients within the PINNACLE Registry - 2020 Quality Summit presentation (Non-CE) - The National Cardiovascular Data Registry

TRANSFORM: LDL – C Risk, an ACC Initiative to Reduce ASCVD Risk Among Secondary Prevention Patients within the PINNACLE Registry - 2020 Quality Summit presentation (Non-CE)

Purpose

TRANSFORM: LDL – C Risk, an ACC Initiative to Reduce ASCVD Risk Among Secondary Prevention Patients within the PINNACLE Registry

Speaker:
Joseph Allen - Team Leader, Clinical Standards and Solution Sets, American College of Cardiology, Washington, DC

Description:
Presentation of the preliminary results for 707 patients enrolled in the TRANSFORM LDL-C Risk within seven practices which implemented a quality improvement.

Learning Objectives:

Discuss how to effectively develop a cohort list of patients for quality improvement.
Recognize the primary reasons for no change in LDL-C therapy.
Explain how to effectively target treatment LDL-C therapy to achieve treatment goals.

Summary


Availability:	On-Demand
	Expires on Jan 05, 2025


Credit Offered:	No Credit Offered